Ribociclib plus standard of care improves PFS in premenopausal HR+/HER2-negative breast cancer

Press/Media: Press / Media

PeriodDec 7 2017 → Dec 8 2017

Media coverage

3

Media coverage

  • TitleRibociclib plus standard of care improves PFS in premenopausal HR+/HER2-negative breast cancer
    Media name/outletOncology Report
    CountryUnited States
    Date12/8/17
    PersonsVirginia G Kaklamani
  • TitleRibociclib plus standard of care improves PFS in premenopausal HR+/HER2-negative breast cancer
    Media name/outletPM 360
    CountryUnited States
    Date12/7/17
    PersonsVirginia G Kaklamani
  • TitleRibociclib plus standard of care improves PFS in premenopausal HR+/HER2-negative breast cancer
    Media name/outletFrontline Medical News
    CountryUnited States
    Date12/7/17
    PersonsVirginia G Kaklamani